Audit finds mistakes but no legal violation in Covid-19 vaccine procurement
An external investigation into the Swiss government’s procurement of Covid-19 vaccines has revealed that two contracts with vaccine manufacturers were signed prior to parliament’s sign-off of funds. However, this didn’t constitute a legal violation.
This content was published on
2 minutes
Keystone-SDA/jdp
Português
pt
Auditoria encontra erros, mas nenhuma violação legal na aquisição da vacina contra a Covid-19
Health minister Alain Berset requested the external investigationExternal link when questions were raised in summer 2022 about whether parliament could agree to a supplementary loan for the procurement of more Covid-19 vaccines. The government administration began to scrutinise all credits and vaccine contracts, uncovering two cases whereby contracts with vaccine manufacturers were not covered by the credits.
In one case the contract was signed with a manufacturer in May 2021 but parliament didn’t approve the necessary funds until June 7, 2021.
The external investigation, publishedExternal link on Wednesday, which was carried out by a former head of the Swiss federal audit office, confirmed the original findings by the government administration “in full”, but indicated that no legal or contractual obligations had “been intentionally violated”.
The investigation also revealed though that not all contracts ensured that parliament could change the orders without violating contractual obligations.
It was also critical of how the government managed credits and offered ten recommendations for the future. This included involving people involved in finance more closely.
In June 2022, the government was forced to slash its order for more Covid-19 vaccines in half to seven million doses after parliament said the order was excessive for a population of 8.7 million people. In May the Federal Office of Public Health confirmed that around 620,000 doses of Moderna vaccine in its existing stockpile had been destroyed because they had expired.
Authorities have ordered 36 million doses from Pfizer/BioNTech, Moderna, AstraZeneca, Curevac and Novavax. In August 2021, the government signed a deal with Pfizer/BioNTech to supply vaccines for the next two years.
Switzerland to introduce flight passenger database
This content was published on
Switzerland plans to introduce a flight passenger database to collect and process personal data in a bid to combat terrorism and serious crime.
Government plans to invest over CHF16bn in Swiss rail network
This content was published on
The federal government intends to invest CHF16.4 billion ($18.1 billion) in railway infrastructure between 2025 and 2028, CHF2 billion more than for the current period.
Swiss to vote on pension reform and biodiversity in September
This content was published on
Swiss citizens will vote on occupational pension schemes and a biodiversity initiative on September 22, the Federal Council announced on Wednesday.
Ukraine peace talks: 50 countries have confirmed participation
This content was published on
To date, 50 countries out 160 invited delegations have confirmed they will attend the Ukraine peace conference, held in central Switzerland in mid-June, according to Swiss public radio, RTS.
Federer-backed On boosts forecast after sneaker demand rises
This content was published on
Swiss footwear company On Holding AG posted strong first-quarter revenue, boosted by demand for its running shoes and new line of training apparel.
Michael Schumacher’s watches fetch CHF4 million at Swiss auction
This content was published on
Watches belonging to Formula 1 great Michael Schumacher sold for around CHF4 million ($4.41 million) at auction house Christie's in Geneva on Tuesday.
Macron will attend Swiss summit on Ukraine, says Zelensky
This content was published on
French President Emmanuel Macron will attend the peace conference on Ukraine at the Swiss Bürgenstock resort next month, according to Volodymyr Zelensky.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.